Depressed CD3+ and CD8+ T cell content and dampened expression of T cell cytolytic markers detected in tumors after VSG intervention could have hindered effective anti-tumor immunity after bariatric surgery-associated weight loss. The gene discussed is CD8A; the disease is neoplasm.